The Therapeutic Goods
Administration is urging product
sponsors to take immediate steps
to amend any labels affected by the
new requirements in the Required
Advisory Statements for Medicine
Labels (RASML) No. 3, which will
become effective 01 Jul 2017.
The updated labelling statements
reflect public consultations and
new Conditions of Listing over the
last couple of years, with items
affected including OTC cough
medicines, OTC nasal decongestant
preparations, esomeprazol,
metoclopramide, chloramphenicol
and NSAIDs for oral use.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Feb 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.